Acarosan

Quick links to important sections

Acarosan

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acarosan

Quick Facts

Property Description
Active Ingredient Benzyl Benzoate
Form Solution, Concentrate, Emulsion, Spray
Pharmacological Class Ectoparasiticide, Acaricide
General Purpose Control and reduction of external parasites (e.g., mites)
Origin Synthetic Compound

Acarosan: Definition, Active Ingredient, and Core Classification

Acarosan is a specialized antiparasitic product classified as an ectoparasiticide and acaricide, primarily containing the active ingredient, Benzyl Benzoate. The substance is a synthetic compound that is chemically categorized as a benzoic acid ester. This pharmacological class is specifically focused on eliminating organisms living on the host's surface or within its immediate environment. The utility of Benzyl Benzoate is recognized for its action against various arthropods.

What Forms of Acarosan are Available and What is its General Purpose?

Acarosan is typically prepared as a single-ingredient product, generally formulated as a solution, concentrate, emulsion, or spray, enabling either topical or environmental application. A differentiating factor for the Acarosan brand is its specific focus on environmental control, often specializing in products designed for thorough application to inanimate objects like bedding and carpets. Its primary purpose is to provide effective control by facilitating the reduction of external parasitic organisms, chiefly house dust mites, thereby addressing the issue at its environmental source.

Understanding Acarosan's Acaricidal Action

Acarosan works by acting as a contact poison that causes neurotoxic disruption in mites and other target arthropods, leading to their swift elimination. This mechanism is associated with a reliable acaricidal effect against the target pests. The compound exhibits larvicidal and ovicial properties, meaning it not only kills adult organisms but also actively interrupts the reproductive cycle by destroying eggs and larvae. This ability to neutralize all stages of the parasite’s life cycle is central to achieving sustained control and preventing the immediate resurgence of the mite population.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Acarosan?

Possible Side Effects and Safety Information

The safety profile for the active ingredient, Benzyl Benzoate, is structured around localized effects and the risk of systemic absorption, as documented in official regulatory sources. The most frequently observed adverse reactions affect the Skin and Subcutaneous Tissue Disorders.

Documented Adverse Reactions

The majority of side effects are categorized as local skin irritation. These reactions commonly include a transient burning sensation, local erythema (redness), and pruritus (itching of the skin). Less commonly, more pronounced reactions such as blister formation, crusting, oozing, and scaling have been documented. Hypersensitivity reactions, including allergic or irritant dermatitis, are also officially listed adverse effects.

Serious Safety Considerations

Severe adverse reactions are primarily linked to accidental ingestion or excessive systemic absorption. These serious effects, which affect the Nervous System and Renal and Urinary Disorders, may include symptoms such as jerking movements, sudden loss of consciousness, and difficulty in urinating. Such effects underscore the need to adhere to official regulatory constraints on use.

Population and Contextual Safety Notes

Regulatory information notes specific caution for older adults, stating the product may worsen pre-existing dry skin conditions. Furthermore, Benzyl Benzoate is contraindicated in individuals with known hypersensitivity to the substance. Use is restricted on open wounds, cuts, or sores, and contact with mucous membranes and eyes must be strictly avoided, as these factors significantly increase the risk of systemic absorption and associated serious effects.

Overdose and Emergency Response

The official overdose profile for Acarosan (Benzyl Benzoate) is defined by the potential for toxicity through two primary exposure routes: accidental oral ingestion and excessive topical application. Manifestations following ingestion are concentrated in the Central Nervous System (CNS), commonly including CNS stimulation, excitation, and convulsions. Reports also document systemic symptoms that can arise from absorption following application beyond standard limits, especially with repeated excessive use.

Potential Severe Outcomes
Convulsions and Sudden Loss of Consciousness
Toxic Hepatitis (potential chronic effect)

The regulatory guidance strongly mandates that immediate medical attention must be sought if poisoning is suspected or if severe neurological signs, such as convulsions or sudden loss of consciousness, occur. This critical action is required because the official labeling confirms that no specific antidote is known for Benzyl Benzoate poisoning.

Therefore, treatment focuses strictly on supportive measures and necessary procedural decontamination. For oral overdose, this includes steps such as gastric lavage or aspiration, as specified in regulatory documents. Anticonvulsants may be administered as part of the symptomatic management if seizures are present. This structured approach, emphasizing procedural intervention and supportive care, outlines the emergency actions required by authoritative health agencies.

Therapeutic Uses of Acarosan

What Acarosan Treats: Main Uses and Benefits

The therapeutic application of Acarosan (Benzyl Benzoate) is considered relevant across domains involving the control of external parasitic agents and the mitigation of subsequent symptomatic distress. Benzyl Benzoate is commonly used to help with conditions caused by mites, including treating scabies and lice infestations.

Management of Ectoparasitic Infestations and Associated Distress

This domain covers the use of the active component in conditions characterized by periods of heightened symptoms caused by external parasitic arthropods. The treatment is applied in scenarios requiring the management of the parasitic source, even in cases involving recurrent or episodic manifestations like crusted scabies. This use offers therapeutic support by helping to ease the severe, persistent itching and skin irritation that may interfere with daily comfort and sleep stability during symptomatic episodes.

“The treatment is commonly used for managing the parasitic source, which contributes to easing overall patient distress and discomfort.”

Reduction of Environmental Allergen Triggers

Acarosan is commonly used as a targeted measure for environmental allergen control in the home, which is relevant for individuals with asthma or allergic rhinitis linked to house dust mite sensitivity. The product is applied in scenarios requiring additional management of discomfort by reducing the presence of mite allergens in household items like carpets and bedding. This strategy may be part of symptomatic management that generally contributes to improved comfort during symptomatic periods and assists with maintaining functional stability by reducing the presence of environmental triggers.


Quick Fact: Relief for Severe Pruritus

Use Category Conditions and Scenarios Primary Symptom Relief
Infestation Control Scabies, Lice, Crusted Scabies Severe, disruptive, nocturnal itching
Environmental Control House Dust Mite Allergy, Asthma, Rhinitis Heightened allergic airway/mucosal sensitivity

Regulatory References

  1. MedlinePlus Medical Encyclopedia overview on Scabies

Eligibility and Restrictions for Use

Who Can and Cannot Use Acarosan?

The population eligibility for using Acarosan (Benzyl Benzoate) is strictly defined by regulatory documents, setting clear boundaries for use and non-eligibility. Adults are the primary population group for whom use is established under standard labeled conditions.

Absolute Contraindications

Use is contraindicated in individuals with a known hypersensitivity or allergy to the active ingredient, Benzyl Benzoate, or any of the product's excipients. Application is prohibited on broken skin, acutely inflamed skin, secondarily infected skin, and must not contact the eyes or mucous membranes.

Restricted and Conditional Eligibility

Age-Specific Rules: The product is not recommended for children unless subject to specific dilution requirements that vary by age. Infants and young children must only be treated under specific medical supervision. Information regarding specific safety or dosage adjustments for older adults is often noted as not established.

Physiological Status: Use during pregnancy is typically advised to be with caution or only when considered essential, due to insufficient data. Breastfeeding must be suspended until the product has been completely washed off the body to prevent infant exposure.

Comorbidity: Cautions exist for high-volume use in patients with hepatic or renal impairment due to the risk of accumulation of certain excipients.

What should I know about interactions with other medicines?

Acarosan (Benzyl Benzoate) possesses an official interaction profile documented by regulatory authorities that is primarily defined by the minimal potential for systemic interactions.

Systemic Drug-Drug Interaction Status

Regulatory prescribing information for Benzyl Benzoate preparations typically reports the Systemic Drug-Drug Interaction Status as "None reported." This classification signifies that there are no documented interactions involving metabolic enzymes, such as cytochrome P450 (CYP) enzymes, or drug transporters. Consequently, no systemic medicinal products are explicitly listed as having formally contraindicated co-administration. Furthermore, official labels do not impose mandatory timing-based rules for separating the administration of Acarosan from other systemic medicines.

Pharmacodynamic (Local) Interaction Risk

The only specific interaction caution documented by regulatory authorities is confined to the Pharmacodynamic (Local) Interaction Risk at the site of application. Co-administration with other topical products or treatments applied to the same skin area may result in an increase in local skin reactions or irritation. This interaction is attributed to the additive irritant properties of excipients, such as Sodium laurilsulfate (SLS), present in some formulations.

Food, Alcohol, and Supplement Interaction Status

Regulatory documents state that no specific interactions with food, alcohol, or herbal supplements are officially documented. No population-specific interaction considerations, such as a heightened risk for individuals with hepatic impairment, are specified in the current official labeling.

Mechanism of Action

How Acarosan Works: Mechanism of Action

Acaricidal Action: Eliminating the Irritant Source

This domain utilizes the active ingredient, benzyl benzoate, functioning as a lethal contact agent against the mites. It is absorbed by the dust mites and disrupts their neural signaling pathways, leading to their demise. This mechanism stops the production of new allergens, resulting in a decrease in the concentration of the environmental source organism.


Allergen Binding: Immobilizing Particulate Irritants

This complementary mechanism employs physical agents that coat and encapsulate microscopic allergenic proteins, such as Der p 1, found in mite waste. By increasing the particles' mass, this action immobilizes the irritants, preventing their aerodynamic suspension. The resulting physiological effect is the reduction of airborne particle concentration, limiting their availability for respiratory or dermal interaction.


Niche Disruption: Inhibiting Colony Growth

This domain involves the action of surfactants that solubilize and remove the organic debris which constitutes the mites' essential food source. By modifying the mites' ecological niche and eliminating their nutrients, this mechanism suppresses their ability to reproduce and form new colonies. This continuous pressure supports the sustained reduction of the irritant source concentration.

Dosage and Administration Information

The administration of Acarosan (Benzyl Benzoate) is defined by a strict, short-term treatment protocol based on the topical route (cutaneous application). The standard concentration available for adult use is a 25% w/v emulsion or lotion. The prescribed use is strictly external only, and the medicine must be applied to clean, dry skin.

Dosing Schedule and Application Area

Condition Administration Regimen Application Area
Scabies Applied for two consecutive nights. The entire body from the soles of the feet up to the neck.
Lice Typically a single application is used. Confined to the affected area, such as the hair and scalp.

Each application requires a specific contact time on the skin, generally ranging from 8 to 24 hours, before the application is thoroughly washed off. The treatment course is short-term, and re-treatment for persistent infestation is a specific procedural decision, often considered 7 days after the initial course is completed.

Age-Specific Dosing Rules

The 25% w/v concentration mandates dilution with water for pediatric patients to achieve the required lower strength. This preparation requires shaking the bottle well before use. For older children, the standard is a 1:1 dilution resulting in a 12.5% concentration, while infants require a 1:3 dilution to achieve a 6.25% concentration.

Recent Clinical Evidence

Research evidence / Overview of studies for Acarosan


Evidence for use in Treating Scabies Infestations

Research for the active ingredient in Acarosan, Benzyl Benzoate, was studied for its use in treating the parasitic skin condition, scabies. The primary evidence in this area comes from Randomized Controlled Trials (RCTs), where the treatment was evaluated in patient groups, often comparing it against other pharmacological anti-parasitic agents. Researchers examined populations spanning adults and children, aiming to measure outcomes related to physical discomfort, including the clinical cure rate and the degree of pruritus improvement.

The studies focused on conditions characterized by periods of heightened symptoms like severe, persistent itching. Research describes observations of clinical cure rates, and research highlights changes measured during the study period related to the improvement of itching symptoms. However, systematic reviews indicate that comparative evidence was observed in some studies to be mixed or inconsistent when assessed against other pharmacological alternatives. Studies monitored patterns related to adherence, and research describes observations suggesting that the performance measured in trials was often linked to the specific application protocol utilized.

Evidence for use in Environmental Allergen Control

Research was also studied for the use of Benzyl Benzoate-containing products for environmental allergen control, which is relevant in conditions involving periods of heightened symptoms like asthma or allergic rhinitis linked to house dust mite (HDM) sensitivity. Trials, often placebo-controlled, research examined populations of adults and children with known HDM sensitization. These studies explored two distinct outcomes: the allergen biomarker levels (concentrations of mite allergens measured in household dust) and patient-reported outcomes describing perceived discomfort related to allergic symptoms or functional axes monitored.

Studies report how symptoms evolved in the observed populations, and research describes documented patterns related to the measurable presence of HDM allergen levels in treated items like carpets and bedding. However, when researchers evaluated the clinical outcomes, such as changes in allergic symptoms or functional axes monitored, the findings were mixed. Research provides insight into short-term changes in allergen levels, but findings indicate that a direct and consistent shift in clinical symptoms has not been clearly established across all trials.


What is still uncertain about Acarosan Research

The available evidence highlights what is known — and what is still uncertain. For treating scabies, the evidence quality varies across studies, leading to conflicting results in comparative trials against other anti-parasitic agents; this certainty remains low in terms of the conclusions drawn from comparative trials. For environmental control, the most notable uncertainty surrounds the disconnect between the measured outcomes: research consistently describes reduced allergen levels, but these findings may not translate consistently into parallel improvements in patient-reported outcomes describing perceived discomfort. Overall, the sample sizes were modest in some key studies, and long-term effects are not fully established, meaning the results apply only to the populations studied and the specific conditions under which they were observed.

Key Studies & References

  1. Permethrin Versus Benzyl Benzoate for the Treatment of Scabies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  2. European guideline for the management of scabies (IUSTI/EADV)

Frequently Asked Questions (FAQ)

Common questions about Acarosan (FAQ)


Q: How often do most people need to apply Acarosan?

Studies and official information indicate that the required application frequency for long-term environmental control is not uniformly established. Research has primarily examined the measurable results of a single treatment at specific time points, such as three and six months after use. This indicates that the effect on allergen concentration is not permanent, and repeat application has been examined in studies to maintain the observed reduction.


Q: Is it okay to use Acarosan if I have asthma?

Regulatory safety information states that the substance is irritating to the respiratory tract, and inhalation should be avoided. Research studies have included populations with house dust mite sensitization, which is a factor in conditions such as asthma, when examining the product’s effect on measurable allergen levels. Proper ventilation of the treatment area is important during use.


Q: Can I use Acarosan if I'm taking other allergy medicine?

According to the official regulatory prescribing information for the active ingredient, the systemic drug-drug interaction status is reported as 'None known.' This classification signifies that no formal contraindications or mandatory timing rules are imposed for co-administration with other systemic medicines.


Q: Is Acarosan approved by a major health agency like the FDA or EMA?

The active ingredient in Acarosan, Benzyl Benzoate, is recognized by the World Health Organization (WHO) and the US Food and Drug Administration (FDA) for its intended uses. For environmental control, the substance is registered as a non-agricultural pesticide for dust mite control with regulatory bodies such as the US Environmental Protection Agency (EPA).


Q: What is the typical time frame to notice benefits from Acarosan?

Researchers have examined changes in allergen levels at specific follow-up time points, with measurements often occurring at three and six months post-application. These studies provided insight into the measured effects on allergen concentration following the treatment.


Q: Is Acarosan a pesticide or a medicine?

The product is officially classified by regulatory bodies as both an ectoparasiticide or acaricide (a pharmacological class) and is also registered as a non-agricultural pesticide for environmental control. This dual classification reflects its intended use on both the human body for parasitic conditions and on inanimate objects to control mites.


Q: How fast does Acarosan start working?

The product acts as a contact agent, and in controlled laboratory studies, the active ingredient has demonstrated a rapid lethal effect on target mites upon exposure. This mechanism is clinically recognized for its reliable acaricidal effect.


Q: Can I use Acarosan on my mattress and carpet at the same time?

Official information and research indicate the product is registered and studied for application on various common household surfaces that harbor mites. These surfaces typically include mattresses, upholstered furniture, and carpets.


Q: Is Acarosan the same as a regular vacuuming or dusting?

No, the action of Acarosan is chemically distinct from mechanical cleaning methods like dusting or vacuuming. It functions as a neurotoxic contact agent against the mites themselves and physically immobilizes allergenic proteins, unlike mechanical removal processes.


Q: Can using too much Acarosan cause problems?

Regulatory patient guidance advises against using the product in excess of recommendations, as greater systemic absorption can increase the risk of side effects. This includes a documented risk of serious effects on the nervous system, such as jerking movements or convulsions.


Q: What happens if my pet touches the treated area right after I use Acarosan?

While the active ingredient is used in some veterinary applications, official safety guidelines advise keeping children and pets away from the immediate area during the use and drying period, consistent with the recommendation for adequate ventilation.


Q: Are there different types of Acarosan products?

Yes, for environmental control purposes, the product has been described in different formulations. These forms include a powder, foam, or spray, which allow for application to various inanimate objects.


Q: How does Acarosan compare to other non-drug dust mite treatments?

Research trials have examined the product’s measured outcomes by comparing its effect on allergen levels against other methods used for mite control. These studies focused on measurable biomarker levels in household dust.


Q: Is the effect of Acarosan permanent?

Official information and research indicate that the effect of Acarosan is not permanent. Studies that examined allergen reduction at six months post-application suggest that the concentration of allergens may begin to rise again over time. Repeat application has been studied as a method to maintain the observed reduction.


Q: Why do some people say Acarosan smells strange?

Regulatory safety documents describe the active ingredient, Benzyl Benzoate, as having a characteristic odor. This is often noted as a light, balsamic odor, and some commercial formulations may include additional perfumes.


Q: Does Acarosan only work on dust mites or other allergens too?

The product is classified as an acaricide specifically targeting dust mites. However, its mechanism of action also involves coating and immobilizing microscopic allergenic proteins, such as Der p 1, which are produced by the mites.


Q: Can Acarosan be used in a car or RV?

Regulatory pest control guidance suggests that the product can be applied to non-washable articles that harbor mites. This includes upholstered furniture, car seats, and other soft furnishings often found in cars or recreational vehicles.


Q: Is Acarosan safe for people with highly sensitive respiratory systems?

Regulatory safety documents state that the substance is irritating to the respiratory tract. For this reason, regulatory documents recommend ensuring adequate ventilation and avoiding inhalation during and immediately after application to minimize exposure.


Q: Does Acarosan treat the root cause of my allergies?

The product’s function is described as addressing the environmental source of irritants by eliminating dust mites and reducing the concentration of allergens in the home. It is not intended to provide a treatment for the underlying systemic allergic condition itself.


Q: Is it okay to use Acarosan on delicate fabrics?

Official information notes that the substance may damage certain plastics. Because the formula may contain alcohol or other excipients, the potential for damage indicates that careful consideration is required before application on delicate or chemically sensitive materials.


Q: Can I use Acarosan while my kids or pets are in the house?

Official guidelines strongly advise storing the product out of reach of children and pets. It is recommended to use the product only with adequate ventilation and to follow all safety precautions during the application process.

How should Acarosan be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory documents define the required storage and disposal conditions for this product, focusing on safety and compliance.

Storage and Handling

Requirement Classification
Storage Environment Store in a cool, dry area.
Container Integrity Keep container tightly closed when not in use.
Child Safety Store OUT OF REACH OF CHILDREN.
Handling Precaution Use only as directed and with adequate ventilation.

Disposal Instructions

Official disposal rules require compliance with all waste management guidelines and prohibit container reuse.

Requirement Details
Disposal Compliance Must comply with all Federal, State, and local laws and regulations.
Container Rule Do not reuse empty container; wrap before placing in disposal system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acarosan found in:

A-Z Index: